Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The study is a pilot trial to investigate the effect of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus Patients.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Namyi Gu
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Diagnosed as a diabetes mellitus patient at least 3 months ago on screening

• Treated with metformin of ≥ 500 mg/day over 3 months on screening

• Fasting glucose level of 110~180 mg/dl or HbA1c of 7.0~9.0% on screening

Exclusion Criteria:

• With acute or chronic inflammation

• Treated with systemic corticosteroids within 4 weeks prior to the first administration of study medication

• With heart failure, myocardial infarction, stroke, or other acute severe cardiovascular diseases

• With acute or chronic renal failure or nephrotic syndrome

• With impaired hepatic function.

• Drug or Alcoholic abuser

• Pregnant or nursing woman